FDA Import Refusal 112-7999232-5/1/1 — Merck Sharpe & Dohme
The FDA refused shipment 112-7999232-5/1/1 from Merck Sharpe & Dohme (Egypt) on Sep 20, 2005. The refused product falls under Drugs and Biologics — CLOMIPHENE CITRATE (GONAD-STIMULATING PRINCIPLE). Cited charge: 75 This firm has 2 other import refusals on record.
Refusal details
- Date
- Sep 20, 2005
- Country
- Egypt
- Product Category
- Drugs and Biologics
- Product Code
- 64MCB01 CLOMIPHENE CITRATE (GONAD-STIMULATING PRINCIPLE)
- Charges
- 75